<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Iqe Plc — News on 6ix</title>
<link>https://6ix.com/company/iqe-plc</link>
<description>Latest news and press releases for Iqe Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 28 Apr 2026 06:45:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/iqe-plc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d581b1beedb30cb6f8a93b.webp</url>
<title>Iqe Plc</title>
<link>https://6ix.com/company/iqe-plc</link>
</image>
<item>
<title>Disclosure Table</title>
<link>https://6ix.com/company/iqe-plc/news/disclosure-table-53</link>
<guid isPermaLink="true">https://6ix.com/company/iqe-plc/news/disclosure-table-53</guid>
<pubDate>Tue, 28 Apr 2026 06:45:00 GMT</pubDate>
<description>The Takeover Panel has updated its Disclosure Table, noting no additions or deletions but providing details on various offer periods. Notably, VertiGIS Ltd is identified as the offeror for 1Spatial plc, TA Associates (UK), LLP for Advanced Medical Solutions Group plc, and CCP Paw 2 Limited for Animalcare Group plc. Additionally, LAC 10 LLC is the offeror for Amedeo Air Four Plus Limited, and Zurich Insurance Group Ltd for Beazley plc, with specific offer periods and identified offerors for sever</description>
</item>
<item>
<title>IQE plc: RetailBook Offer</title>
<link>https://6ix.com/company/iqe-plc/news/iqe-plc-retailbook-offer</link>
<guid isPermaLink="true">https://6ix.com/company/iqe-plc/news/iqe-plc-retailbook-offer</guid>
<pubDate>Mon, 27 Apr 2026 16:00:00 GMT</pubDate>
<description>IQE plc has announced a conditional retail offer of new ordinary shares at an issue price of 19.8 pence per share, representing a discount of approximately 10.1% to the 12-month VWAP and a significant 58.4% discount to the closing mid-market price of 47.6 pence on April 24, 2026. This offer is exclusively for existing UK retail shareholders, with a minimum subscription of £250, and is conditional on the completion of a separate placing to institutional investors. The net proceeds from the overal</description>
</item>
<item>
<title>IQE plc: Rule 2.9 Announcement</title>
<link>https://6ix.com/company/iqe-plc/news/iqe-plc-rule-29-announcement</link>
<guid isPermaLink="true">https://6ix.com/company/iqe-plc/news/iqe-plc-rule-29-announcement</guid>
<pubDate>Thu, 16 Apr 2026 06:40:00 GMT</pubDate>
<description>IQE plc has announced the allotment and issuance of 6,483 new ordinary shares, valued at 1 pence each, to satisfy the exercise of options by employees under its Long Term Incentive Plan. These new shares rank equally with existing ordinary shares. As of the close of business on April 15, 2026, IQE confirmed it has 979,251,736 ordinary shares in issue, each with voting rights and admitted to trading on the London Stock Exchange under ISIN GB0009619924.
Disclaimer*</description>
</item>
<item>
<title>IQE plc: Block Admission</title>
<link>https://6ix.com/company/iqe-plc/news/iqe-plc-block-admission</link>
<guid isPermaLink="true">https://6ix.com/company/iqe-plc/news/iqe-plc-block-admission</guid>
<pubDate>Thu, 02 Apr 2026 06:00:00 GMT</pubDate>
<description>IQE plc has applied to the London Stock Exchange for a block admission of 22,000,000 ordinary shares of 1p each to trading on AIM, effective from 8:00 am on April 7, 2026. These shares will be issued to satisfy obligations under the company's Long Term Incentive Plan, which incentivises all employees annually. The new shares will rank pari passu with existing ordinary shares, and there is no change to the Group's issued share capital as a result of this admission.
Disclaimer*</description>
</item>
<item>
<title>IQE plc: Total Voting Rights</title>
<link>https://6ix.com/company/iqe-plc/news/iqe-plc-total-voting-rights</link>
<guid isPermaLink="true">https://6ix.com/company/iqe-plc/news/iqe-plc-total-voting-rights</guid>
<pubDate>Wed, 01 Apr 2026 06:00:00 GMT</pubDate>
<description>IQE plc has announced its total voting rights as of March 31, 2026. The company's issued share capital comprises 979,142,070 ordinary shares, with 4,115 shares held in treasury, resulting in 979,137,955 ordinary shares with voting rights. This figure serves as the denominator for shareholders to determine notification requirements under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Disclaimer*</description>
</item>
<item>
<title>IQE plc: Holding(s) in Company</title>
<link>https://6ix.com/company/iqe-plc/news/iqe-plc-holdings-in-company</link>
<guid isPermaLink="true">https://6ix.com/company/iqe-plc/news/iqe-plc-holdings-in-company</guid>
<pubDate>Thu, 26 Mar 2026 11:00:00 GMT</pubDate>
<description>Spreadex LTD has notified IQE PLC of a change in its major holding, crossing a threshold on March 24, 2026. Following this event, Spreadex LTD now holds 0.0871% of voting rights attached to shares and 2.7182% through financial instruments, resulting in a total of 2.8053% of voting rights, representing 27,466,199 voting rights. This is a decrease from their previous notification where they held 3.9700% in total.
Disclaimer*</description>
</item>
<item>
<title>IQE plc: Rule 2.9 Announcement - Replacement</title>
<link>https://6ix.com/company/iqe-plc/news/iqe-plc-rule-29-announcement-replacement</link>
<guid isPermaLink="true">https://6ix.com/company/iqe-plc/news/iqe-plc-rule-29-announcement-replacement</guid>
<pubDate>Mon, 02 Mar 2026 15:48:00 GMT</pubDate>
<description>IQE plc has issued an amendment to a previous announcement, confirming the allotment and issuance of 2,144 new ordinary shares to satisfy employee option exercises under its Long Term Incentive Plan. As of the close of business on February 27, 2026, the company now has 978,699,475 ordinary shares with voting rights in issue. All other details from the original announcement remain unchanged.
Disclaimer*</description>
</item>
<item>
<title>IQE plc: Trading Update</title>
<link>https://6ix.com/company/iqe-plc/news/iqe-plc-trading-update</link>
<guid isPermaLink="true">https://6ix.com/company/iqe-plc/news/iqe-plc-trading-update</guid>
<pubDate>Mon, 12 Jan 2026 07:00:00 GMT</pubDate>
<description>IQE plc reported strong trading momentum in the second half of 2025, driven by increased demand in military and defence, AI, data centre, and handset markets, leading to expected full-year 2025 revenue of approximately £97 million and adjusted EBITDA of at least £2.0 million. The company ended 2025 with a cash position of £15.6 million and has secured a waiver for its Q4 2025 EBITDA covenant test from HSBC. IQE enters 2026 with a robust Q1 order book, indicating improved demand visibility across</description>
</item>
<item>
<title>IQE plc: Total Voting Rights and Block Admission</title>
<link>https://6ix.com/company/iqe-plc/news/iqe-plc-total-voting-rights-and-block-admission</link>
<guid isPermaLink="true">https://6ix.com/company/iqe-plc/news/iqe-plc-total-voting-rights-and-block-admission</guid>
<pubDate>Mon, 05 Jan 2026 16:00:00 GMT</pubDate>
<description>IQE plc has reported that as of December 31, 2025, the company has 978,259,501 ordinary shares with voting rights. The company also provided an update on its block admission for an all-employee share option plan, stating that 1,758,054 ordinary shares were issued under the scheme between July 1, 2025, and December 31, 2025, leaving a balance of 4,773,780 ordinary shares yet to be issued under the scheme.
Disclaimer*</description>
</item>
<item>
<title>IQE plc: Strategic supply agreement with Lumentum</title>
<link>https://6ix.com/company/iqe-plc/news/iqe-plc-strategic-supply-agreement-with-lumentum</link>
<guid isPermaLink="true">https://6ix.com/company/iqe-plc/news/iqe-plc-strategic-supply-agreement-with-lumentum</guid>
<pubDate>Mon, 08 Dec 2025 07:00:00 GMT</pubDate>
<description>IQE plc has announced a multi-year extension to its strategic supply agreement with Lumentum Holdings Inc. for epiwafers used in advanced sensing technologies, building on a long-standing relationship that has advanced 3D Sensing technologies for consumer, automotive LiDAR, and in-cabin sensing applications. This extension signifies continued collaboration and innovation in critical sensing markets, suggesting positive future revenue streams for IQE.
Disclaimer*</description>
</item>
<item>
<title>IQE plc: Director/PDMR Shareholding</title>
<link>https://6ix.com/company/iqe-plc/news/iqe-plc-directorpdmr-shareholding</link>
<guid isPermaLink="true">https://6ix.com/company/iqe-plc/news/iqe-plc-directorpdmr-shareholding</guid>
<pubDate>Mon, 01 Dec 2025 13:30:00 GMT</pubDate>
<description>IQE plc announced that on December 1, 2025, Executive Chair Mark Cubitt was granted immediately vested, nil-cost options for 166,667 ordinary shares under the company's Long Term Incentive Plan. Further options are planned for March 2026, bringing the total potential grant to 666,667 ordinary shares, all subject to a three-year holding period from the grant date.
Disclaimer*</description>
</item>
<item>
<title>Form 8.3 - IQE PLC</title>
<link>https://6ix.com/company/iqe-plc/news/form-83-iqe-plc-12</link>
<guid isPermaLink="true">https://6ix.com/company/iqe-plc/news/form-83-iqe-plc-12</guid>
<pubDate>Thu, 23 Oct 2025 08:46:00 GMT</pubDate>
<description>LONDON, October 23, 2025-- FORM 8.3</description>
</item>
<item>
<title>Exercise of Options, Issue of Equity & Rule 2.9</title>
<link>https://6ix.com/company/iqe-plc/news/exercise-of-options-issue-of-equity-and-rule-29</link>
<guid isPermaLink="true">https://6ix.com/company/iqe-plc/news/exercise-of-options-issue-of-equity-and-rule-29</guid>
<pubDate>Wed, 01 Oct 2025 12:17:00 GMT</pubDate>
<description>IQE plc announced the allotment and issuance of 3,275 new ordinary shares at 1 pence each, resulting from the exercise of options by employees under the IQE Long Term Incentive Plan. These new shares rank equally with the existing shares. As of September 30, 2025, IQE confirms it has 977,551,249 ordinary shares of 1 pence each issued (outside of treasury) with voting rights, trading on the London Stock Exchange under ISIN code GB0009619924.
Disclaimer*</description>
</item>
<item>
<title>IQE plc: H1 2025 Interim Results</title>
<link>https://6ix.com/company/iqe-plc/news/iqe-plc-h1-2025-interim-results</link>
<guid isPermaLink="true">https://6ix.com/company/iqe-plc/news/iqe-plc-h1-2025-interim-results</guid>
<pubDate>Tue, 23 Sep 2025 06:00:00 GMT</pubDate>
<description>IQE plc announced its H1 2025 results, revealing a challenging period with revenue decreasing to £45.3 million from £66.0 million in H1 2024. The adjusted EBITDA was a loss of £0.4 million, a significant drop from the £6.6 million EBITDA in the prior year. The adjusted loss before tax was £12.9 million, compared to a loss of £7.2 million in H1 2024. Despite these losses, adjusted net cashflow from operations improved to £6.2 million from £1.8 million. Cash capital expenditure was reduced to £1.0</description>
</item>
<item>
<title>HSBC HOLDINGS PLC ANNOUNCES RESULTS OF ITS TENDER OFFERS FOR FOUR SERIES OF NOTES</title>
<link>https://6ix.com/company/iqe-plc/news/hsbc-holdings-plc-announces-results-of-its-tender-offers-for-four-series-of-notes-199</link>
<guid isPermaLink="true">https://6ix.com/company/iqe-plc/news/hsbc-holdings-plc-announces-results-of-its-tender-offers-for-four-series-of-notes-199</guid>
<pubDate>Tue, 09 Sep 2025 10:52:00 GMT</pubDate>
<description>HSBC Holdings plc (the 'Company', 'we' or 'us') today announces the results of its previously announced four separate offers to purchase for cash any and all of the outstanding series of notes listed in the table below. We refer to the outstanding notes listed in the table below collectively as the 'Notes' and separately as a 'series' of Notes. We refer to each offer to purchase a series of Notes as an 'Offer', and collectively as the 'Offers'.</description>
</item>
</channel>
</rss>